Turning Complex Molecules into Medicines: Leveraging advanced formulation technologies to enable solubility and permeability

In this interview with American Pharmaceutical Review's Editor-in-Chief Mike Auerbach, Serán's President & CEO, Dan Smithey discusses the increasing complexity of molecules, barriers to bioavailability and the enabling science and technologies being leveraged to achieve permeability and solubility. The article explores existing and novel formulation technologies and considerations for each. Dr. Smithey, breaks down Serán's comprehensive approach to address these challenges to help Serán's clients deliver complex medicines to patients sooner.

‍

Learning Objectives:

- Understand the barriers to achieving acceptable pharmacokinetics for oral delivery

- Existing and novel approaches to enabling solubility and permeability for oral solid dosage forms

- Understanding options being explored for improved bioavailability through advanced injectable formulations

‍

Read this complimentary article to learn more about these and other bioavailability enhancing technologies and a development approach that can dramatically reduce time to clinic and launch. Read today!

‍

‍

‍